reference/32855720

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32855720

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	2152
issn	1945-7197 0021-972X
issueIdentifier	6
pageRange	2145-2152
publicationName	The Journal of clinical endocrinology and metabolism
startingPage	2145
bibliographicCitation	Ghali JK, Koren MJ, Taylor JR, Brooks-Asplund E, Fan K, Long WA, Smith N. Efficacy and Safety of Oral Conivaptan: A V_1A/V₂Vasopressin Receptor Antagonist, Assessed in a Randomized, Placebo-Controlled Trial in Patients with Euvolemic or Hypervolemic Hyponatremia. The Journal of Clinical Endocrinology & Metabolism. 2006 Jun;91(6):2145–52. doi: 10.1210/jc.2005-2287.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_093f5c6dc5aa38beda0cebf18af8a7c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13d66cfe7cab960afffdee8f3487c101 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8328dd97a20f1eea2605282770f40a42 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a29752edda3090bc26305c83cccc44a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_363940168250e5782647754c99ce66df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6201798b8d013902ee8f56868bbeb43d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edbcbf21660bd91ada1ae0c3224035d9
date	200606
identifier	https://pubmed.ncbi.nlm.nih.gov/16522696 https://doi.org/10.1210/jc.2005-2287
isPartOf	https://portal.issn.org/resource/ISSN/0021-972X https://portal.issn.org/resource/ISSN/1945-7197 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4624
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and Safety of Oral Conivaptan: A V1A/V2Vasopressin Receptor Antagonist, Assessed in a Randomized, Placebo-Controlled Trial in Patients with Euvolemic or Hypervolemic Hyponatremia
discusses	http://id.nlm.nih.gov/mesh/M0159612 http://id.nlm.nih.gov/mesh/M0002330 http://id.nlm.nih.gov/mesh/M0587243 http://id.nlm.nih.gov/mesh/M0082919 http://id.nlm.nih.gov/mesh/M0020091 http://id.nlm.nih.gov/mesh/M0590166 http://id.nlm.nih.gov/mesh/M0001691 http://id.nlm.nih.gov/mesh/M0387075
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D065092 http://id.nlm.nih.gov/mesh/D007010Q000188 http://id.nlm.nih.gov/mesh/D001552Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001127Q000097 http://id.nlm.nih.gov/mesh/D051544 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D012964Q000097 http://id.nlm.nih.gov/mesh/D001552Q000009 http://id.nlm.nih.gov/mesh/D065607 http://id.nlm.nih.gov/mesh/D007010Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151171 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8135 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8136 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8126 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_349433344be987d594aa70f188dec534 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644077

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128793026 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID552 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244302846

Total number of triples: 62.